Manufacturing & Supply Inquiries · For Qualified Organizations · Confidential Exploratory Conversations
For Qualified Organizations

Strategic Partnerships

Strategic manufacturing, sourcing, and fulfillment solutions for qualified organizations.

ReVia works with qualified healthcare organizations, pharmacies, telehealth companies, manufacturers, and strategic partners evaluating peptide and specialty compound manufacturing, sourcing, packaging, and fulfillment.

Whether you're preparing for regulatory change, evaluating domestic manufacturing, expanding capacity, or exploring strategic supply relationships, we're available for confidential exploratory conversations.

Who We Work With
  • 503A Compounding Pharmacies
  • 503B Outsourcing Facilities
  • Telehealth Organizations
  • Large Medical Practices
  • National Healthcare Platforms
  • Manufacturers & Strategic Partners
U.S. Manufactured
FDA-Registered Facilities
cGMP · ISO
Documented Quality Systems
Domestic Supply
Who We Work With

Organizations evaluating peptide manufacturing and supply.

503A Compounding Pharmacies
503B Outsourcing Facilities
Telehealth Organizations
Large Medical Practices
National Healthcare Platforms
Manufacturers & Strategic Partners
Manufacturing Capabilities

Scalable manufacturing and supply solutions.

Through our manufacturing and strategic partnerships, we support organizations seeking scalable manufacturing and supply solutions for peptides, small molecule compounds, sterile fill & finish, clinical & commercial packaging, private label programs, documentation & quality systems, scale planning, domestic distribution, and commercial supply solutions.

Manufacturing Reality

Manufacturing strategy has become as important as manufacturing itself.

Organizations entering or expanding within the peptide market must balance manufacturing capability, supply-chain reliability, regulatory evolution, scalability, quality systems, and commercial economics.

The definition of "U.S. Manufactured" can vary significantly depending on where synthesis, fill & finish, testing, packaging, and final release occur. Understanding those differences is essential when evaluating manufacturing partners and long-term supply strategies.

Our role is to help organizations evaluate practical manufacturing solutions that align with their technical, commercial, and regulatory objectives.

Why Organizations Contact ReVia

Common questions we help organizations work through.

Domestic manufacturing opportunities
Strategic sourcing options
Outsourcing versus internal production
Manufacturing capacity
Future regulatory positioning
Commercial supply planning
Specialty manufacturing projects
Long-term manufacturing relationships
Industry Engagement

Actively engaged in the conversation shaping this industry.

  • Participation in FDA Pharmacy Compounding Advisory Committee discussions.
  • Collaboration with practitioners, manufacturers, researchers, and industry stakeholders.
  • Ongoing dialogue regarding U.S. manufacturing capacity, supply-chain development, and evolving regulatory considerations.
  • Continuous evaluation of manufacturing models, quality standards, and commercial readiness.

We believe better decisions begin with better information.

Founder

Mike Stone

Founder, ReVia

ReVia was founded by Mike Stone, an entrepreneur whose career has centered on identifying opportunities, solving complex business challenges, and bringing together the right people to create strategic partnerships.

His experience includes structuring and executing complex commercial transactions, strategic partnerships, co-development relationships, financing initiatives, business acquisitions, and growth strategies across multiple industries. Known for his disciplined approach to due diligence and his ability to challenge conventional thinking, Mike focuses on helping organizations evaluate opportunities from multiple perspectives and develop practical solutions.

Today, his work is focused on increasing peptide awareness and responsible availability in the United States by promoting manufacturing transparency, quality systems, and FDA-aligned manufacturing practices. He believes that better information leads to better decisions — for consumers, practitioners, businesses, and policymakers alike.

That philosophy has led Mike to actively participate in discussions surrounding peptide manufacturing, quality, regulatory policy, and the future of domestic manufacturing capacity. His goal is not simply to participate in the conversation, but to help move it forward.

"The more we know, the better decisions we can make."

Our Perspective

The peptide industry is entering a period of significant transition.

Demand continues to grow while manufacturing capacity, regulatory expectations, supply-chain models, and commercial strategies continue to evolve.

Organizations making long-term decisions today need partners who understand not only manufacturing, but the broader ecosystem in which those manufacturing decisions are made.

At ReVia, our role is to help organizations evaluate opportunities, connect the right resources, and identify practical solutions that support long-term success.

Let's Start the Conversation

Let's talk about what you're building.

Whether you're evaluating manufacturing capacity, strategic sourcing, commercial supply, or long-term partnerships, we'd welcome the opportunity to learn more about your objectives.

Every conversation begins with understanding your goals. If there's an opportunity to create value together, we'll explore it. If not, we'll tell you that too.

Start a Strategic Conversation →